Meesho Limited has made a regulatory disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The Nomination and Remuneration Committee (NRC) of the Board of Directors approved, via a circular resolution passed on July 01, 2026, the grant of 3,886 Stock Options to eligible employees under the company's ESOP 2024 Plan.
Key Details of the Grant:
- Total Options Granted: 3,886
- Conversion Terms: Each option is convertible into 49 fully paid-up equity shares of face value Re. 1/- each.
- Total Shares Covered: The grant covers 1,90,414 equity shares of face value Re. 1 each. This figure includes requisite adjustments for corporate actions as provided under the ESOP 2024 Plan.
- Pricing Formula: The exercise price is Re. 1/- per stock option.
- Exercise Period: The options may be exercised at any time after the vesting period, provided the option grantee is still employed by the company. In the event of cessation of employment, all vested options as of the last working day may be exercised within 6 (Six) months from the date of cessation.
- Significant Terms: The ESOP 2024 Plan outlines the treatment of stock options in cases of death, permanent incapacity, resignation, termination, and retirement. Equity shares allotted upon exercise of the stock options will not be subject to any lock-in period.
Current Status:
The disclosure confirms that as of the date of this filing, no options have vested, been exercised, lapsed, or resulted in money being realized or shares being issued. There have been no variations, subsequent changes, cancellations, or exercises of the options granted. A diluted earnings per share (EPS) calculation is not applicable at this time.